In the past decade, Enterococcus species have become an increasingly significant cause of nosocomial infections (8, 12) . Of the infections attributable to enterococci, E. faecalis is currently responsible for approximately 75 to 80% of clinical infections and E. faecium is responsible for the majority of the remainder (12, 13) . Identification of enterococci to the species level is important because it relates to the choice of empiric treatment. Historically, ampicillin resistance has often been used to differentiate E. faecium from E. faecalis, but because of current resistance patterns, this marker is no longer reliable. Consequently, a reproducible and economical alternative to the determination of enterococcal species is desirable.
Elfamycins are naturally occurring antibiotics which inhibit bacterial growth by binding to the protein synthesis elongation factor EF-Tu (22) . These antibiotics are unable to penetrate into many species of gram-negative bacteria, but they are able to inhibit the EF-Tu's of these species in cell-free protein synthesis systems (10, 22, 23) . Among gram-positive species, susceptibility or resistance to elfamycins appears to be determined, instead, by the properties of the EF-Tu's of the organisms. Staphylococci and some species of lactobacilli and Bacillus are resistant to elfamycins (7, 9, 16, 20, 21) , and resistance has been reported, but not extensively studied, among enterococci (14) . We report on the susceptibility patterns of enterococci to elfamycins and on the potential use for these antibiotics as an aid to identification to the species level. We examined the susceptibilities of enterococcal isolates to three elfamycin antibiotics. Kirromycin and aurodox were obtained by fermentation of Streptomyces ramocissimus ATCC 27529 and Streptomyces goldiniensis ATCC 21386, respectively (1, 19 MICs were determined by either of two methods: microdilution in Iso-Sensitest broth (Oxoid) or agar dilution in IsoSensitest agar. Incubation was for 18 to 24 h at 35 to 37°C. In addition, screening tests were carried out by using either an agar disk diffusion or a breakpoint agar dilution approach. Filter paper disks containing 100 ,ug of kirromycin were prepared and were dried at 35°C for 3 h in the dark. Disk susceptibility tests were performed by using inocula standardized to produce semiconfluent growth after overnight incubation at 35°C. The agar breakpoint test was performed by replicating the enterococci (104 CFU) onto Iso-Sensitest agar without antibiotic and onto agar containing 0.1, 1, 10, and 100 jig of kirromycin per ml.
An elfamycin-resistant derivative of E. hirae ATCC 8043 was selected by placing a total of approximately 2 x 10' CFU on Iso-Sensitest agar plates containing 100 jig of kirromycin per ml. One of the three colonies appearing after 24 h of incubation at 37°C was kept for further study, after confirmation (by using a Rapid ID32 Strep gallery) that it was E. hirae. To assay cell-free protein synthesis, E. hirae ATCC 8043 and its kirromycin-resistant derivative (G1679) were grown to the midlogarithmic phase (ca. 2 x 108 CFU/ml) in Iso-Sensitest broth and were centrifuged at 13,000 x g for 10 min at 4°C. The bacteria were washed twice by resuspension in 20 ml of saline (0.85% NaCl) and centrifugation and were then suspended in 5 ml of buffer (10 mM Tris-HCl [pH 7.8], 5 mM MgCl2, 0.1 mM phenylmethylsulfonyl fluoride, 10 jLg of leupeptin per ml, 10 ,ug of trasylol per ml, 100 ,ug of lysozyme per ml, 100 ,ug of lysostaphin per ml, 10 jig of mutanolysin per ml) and incubated for 45 min at 37°C. (All reagents were from Sigma Chemical Co., St. Louis, Mo.) Concentrated supernatants (S-100) and NH4Cl-washed ribosomes were prepared as described previously (10). Cell-free polyuridylate-directed polyphenylalanine synthesis was performed as described previously (9) . After hot trichloroacetic acid treatment, the samples were filtered through glass fiber filters (Whatman GF/C). The filters were immersed in 10 ml of Ultima Gold (Packard) scintillation fluid and were counted in a Packard model 1600TR liquid scintillation spectrometer. The MICs of kirromycin for several species of enterococci are given in Table 1 . The same pattern of results was obtained with efrotomycin and aurodox and when kirromycin was tested on Iso-Sensitest agar containing lysed horse blood or on MacConkey agar (data not shown). Broth microdilution MICs for susceptible isolates were slightly lower when lower inocula (104 CFU/ml) were used, but the susceptibility pattern remained unchanged (data not shown). The disk susceptibility test clearly distinguished resistant and susceptible species (Table 1) . When 67 selected isolates were tested in an agar breakpoint screening test by using a lower inoculum (104 CFU) than that used for agar dilution MICs (105 CFU), all of the susceptible isolates failed to grow on agar containing I ,ug of kirromycin per ml, whereas all of the resistant isolates grew on agar containing 100 ,ug of the antibiotic per ml. Because the agar dilution MICs were 4 p.g/ml for all of the susceptible isolates tested, it would seem reasonable to use 10 ,ug of kirromycin per ml for routine breakpoint testing.
E. faecium, E. durans, and E. hirae were susceptible to the elfamycins, while isolates of E. faecalis and all other species tested were resistant. Resistance to penicillins, aminoglycosides, or glycopeptides had no apparent effect on the pattern of susceptibility to elfamycins (data not shown). These results suggest that susceptibility to elfamycin antibiotics could be used as a rapid screening test to distinguish between the two species most often encountered in clinical specimens (E.
faecalis and E. faecium). Furthermore, it appears that the test has the potential to distinguish E. faecium from E. gallinarum and E. casseliflavus. At present, this differentiation is based on motility and pigment production, tests which tend to be unreliable and may be inconvenient to perform in the clinical laboratory (18) . An additional test may be of value, particularly since E. gallinarum and E. casseliflavus are intrinsically resistant to vancomycin (5, 15) .
We have demonstrated previously that elfamycin resistance in E. faecalis ATCC 7080 was mediated by the intrinsic resistance of its EF-Tu (10). As expected from its susceptibility to elfamycins, a cell-free protein synthesis system from E. hirae ATCC 8043 was inhibited by 50% at concentrations of .1 ,ug of kirromycin or efrotomycin per ml, while protein synthesis in a system derived from the isogenic resistant strain was not inhibited by drug at 100 jig/ml (data not shown).
On the basis of these studies with E. hirae and previous studies with other gram-positive bacteria (7, 9, 10, 16, 20, 21) , it appears that resistance or susceptibility to elfamycins in enterococci is mediated by EF-Tu. Although this protein is considered to be highly conserved among eubacteria (3, 11) , the elfamycin-binding site appears to be less conserved than other portions of the molecule (10) . Studies with Escherichia coli have shown that a single amino acid change in EF-Tu can lead to elfamycin resistance (2, 17) , and the relative ease of isolation in the laboratory of a resistant derivative of E. hirae suggests that this is generally true for bacterial EF-Tu's. However, the fact that in the wild different species within the genus Enterococclus have different susceptibilities to elfamycins, independently of their ecological niches, suggests that selective pressure is low at present, despite the use of these antibiotics in animal husbandry (4) . One may hope, therefore, that clinical isolates of enterococci will maintain their speciesrelated susceptibility pattern in the future and that an elfamycin may be incorporated into a rapid screening test to aid in the determination of species of enterococci.
